SCHEMBL30926360

SCHEMBL30926360

CCCC[Sn](CCCC)(CCCC)c1cnc(C2CCOCC2)n1C

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 19/20 0.42
PDE1B Q01064 18/20 0.42
PDE1A P54750 17/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428068 0.70 ALDH1A1 (0.37)
SCHEMBL8554027 0.69 ALDH1A1 (0.33)
SCHEMBL21449327 0.67 PDE1B (0.44) PDE1CPDE1BPDE1A
SCHEMBL30928708 0.65 NPC1 (0.35)
SCHEMBL19301731 0.64 PDE1B (0.60) PDE1CPDE1BPDE1A
SCHEMBL5254451 0.63 ALDH1A1 (0.42)
SCHEMBL18488318 0.62 DRD2 (0.53)
Dioxane SCHEMBL4259401 0.61 MAPK1 (0.32)
SCHEMBL22498772 0.61 SPHK1 (0.34)
SCHEMBL23566057 0.61 PDE1A (0.50) PDE1CPDE1BPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626423-A1 CDK INHIBITORS AND METHODS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-10-08 EP disclosed
WO-2024119122-A1 CDK INHIBITORS AND METHODS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-06-06 WO disclosed